“Why ADHD Can Feel Different Across Your Menstrual Cycle”

Why can ADHD feel manageable one week and much harder the next? Why does focus sometimes disappear just before your period? And why do some women say their ADHD medication feels less effective at exactly the same point every month?

For a long time, most ADHD research barely considered the menstrual cycle.

That is beginning to change.

In a 2026 study of 600 women who reported an ADHD diagnosis and ADHD symptoms, 88.6% of premenopausal participants who were not using hormonal therapy said their ADHD symptoms changed across their menstrual cycle, with worsening most commonly reported during the luteal phase.

Another 2026 study followed 30 women with ADHD taking amphetamine-based medication every day for 35 days. Their ADHD symptoms changed significantly across the cycle and were most severe during menstruation and mildest during the mid-follicular phase.

So yes: for some women, ADHD really can feel different depending on where they are in their cycle.

The interesting question is why.

First, what actually happens to your hormones across the menstrual cycle?

The menstrual cycle is not simply “high hormones” followed by “low hormones”. Oestrogen and progesterone rise and fall in different patterns across the month.

At the beginning of the cycle, during menstruation, both oestrogen and progesterone are relatively low. During the follicular phase, oestrogen begins to rise and usually reaches a peak around ovulation. It then drops after ovulation.

During the luteal phase, progesterone rises significantly and oestrogen has a smaller second rise. If pregnancy does not occur, both hormones fall again in the days before menstruation.

Those changes matter because ovarian hormones do not only act on the reproductive system.

They act on the brain too.

What does oestrogen have to do with ADHD?

ADHD involves several brain systems, including dopamine and noradrenaline pathways involved in attention, motivation, reward, working memory and behavioural control.

Oestrogen, particularly estradiol, is also active in the brain.

Research shows that estradiol can influence dopamine production, release, receptors, transport and breakdown. It also interacts with serotonin and glutamate systems. Many of these findings come from laboratory and animal research, so the exact effects in the human ADHD brain are still being worked out, but the biological overlap is significant enough that researchers are now studying it directly.

A 2025 systematic review of ADHD and sex hormones concluded that lower-oestrogen environments were the hormonal state most consistently associated with worsening ADHD symptoms, although it also stressed that the evidence base remains small. Only 11 studies met the criteria for the entire review.

So the developing theory is not simply that “low oestrogen causes ADHD”.

ADHD is a neurodevelopmental condition that exists throughout the cycle.

The idea is that changing hormone levels may change the environment in which an ADHD brain is operating.

What happens after ovulation?

This is one of the most interesting parts of the research.

A study followed 32 young women across 35 days, measuring their hormones through daily saliva samples and recording ADHD symptoms each evening.

When estradiol decreased in combination with higher progesterone or testosterone, ADHD symptoms tended to be higher the following day, particularly in women with higher baseline impulsivity.

Later analysis of this work reported that declines in estradiol predicted clinically meaningful increases of around twofold in inattention and hyperactivity-impulsivity symptoms in some participants.

There is an important detail here: these were community-recruited young women rather than a sample made up entirely of women diagnosed with ADHD.

So the finding is fascinating, but it should not be read as “everyone with ADHD gets twice as symptomatic before their period”.

What it does show is that changes in ovarian hormones can be associated with surprisingly large changes in ADHD-like symptoms within the same person.

And the pattern may not be identical for every ADHD symptom

Researchers have proposed that different points of the cycle may affect different symptoms.

The drop in oestrogen immediately after ovulation has been associated with increases in hyperactivity and impulsivity, particularly in more impulsive individuals.

Later in the cycle, as oestrogen falls again before menstruation, inattention and executive-function difficulties may become more noticeable.

A newer 2026 study in women actually being treated for ADHD adds weight to this idea. Researchers asked 30 women taking amphetamine salts to record their symptoms and mood daily through an entire menstrual cycle. Symptoms were highest during menstruation, when oestrogen and progesterone are low, and comparatively lower during the mid-follicular phase as oestrogen rises.

The changes in ADHD symptoms also tracked changes in negative mood.

Which helps explain why the experience can feel like more than simply “I can't concentrate”.

For some women, the difficult part of the cycle may involve attention, motivation, irritability, emotional regulation and the ability to get started all changing at the same time.

Why can ADHD medication feel less effective before your period?

This is reported frequently enough that researchers have started investigating it, but the evidence is still early.

Stimulant ADHD medications work partly by increasing signalling through dopamine and noradrenaline systems. If ovarian hormones are also influencing those same neurotransmitter systems, it is biologically plausible that medication response could feel different at different points of the cycle.

There are some older clues. Studies in healthy women found that the subjective effects of amphetamine were stronger during the follicular phase than the luteal phase, and in one study greater effects were associated with higher oestrogen levels. These were not ADHD treatment studies, so they cannot tell us how prescribed medication should be managed, but they helped establish that ovarian hormones can alter responses to stimulants.

More recently, clinicians reported a small case series involving nine women with ADHD who consistently experienced worsening ADHD and mood symptoms in the premenstrual week, alongside the feeling that their usual medication was no longer working as well.

Their clinicians temporarily increased stimulant medication during the premenstrual period. All nine reported improvements in areas including inattention, irritability and energy, with minimal adverse effects reported during follow-up.

But nine people is a very small study. There was no placebo group and the researchers themselves describe the findings as preliminary.

So this is not evidence to change medication doses yourself.

It is evidence that a question women have been asking for years is finally being studied.

A 2025 review of the available literature reached a similar conclusion: several studies suggest ADHD symptoms worsen during the luteal phase, but cycle-dependent stimulant efficacy remains seriously under-researched.

What does progesterone have to do with it?

Oestrogen tends to get most of the attention, but progesterone may matter too.

After ovulation, progesterone rises substantially. One of its metabolites is allopregnanolone, a neuroactive steroid that interacts with GABA-A receptors, part of the brain's major inhibitory signalling system.

This becomes particularly interesting when we look at PMDD.

Research increasingly suggests that PMDD is not simply caused by having “too much” or “too little” of a particular hormone. Instead, people with PMDD appear to have an altered brain response to otherwise normal hormonal fluctuations, with allopregnanolone and GABA signalling among the mechanisms being investigated.

And ADHD and PMDD appear to overlap much more often than researchers expected.

ADHD and PMDD: the numbers are striking

A 2025 British study looked at 715 women aged 18 to 34.

Among participants reporting a clinical ADHD diagnosis, 31.4% met screening criteria for provisional PMDD.

Among women without ADHD, the figure was 9.8%.

That is more than three times as high.

Researchers also looked at participants whose ADHD symptoms and impairment met a validated questionnaire threshold, even if they did not report a formal diagnosis. In that group, 41.1% screened positive for provisional PMDD.

Women with high ADHD symptoms alongside depression and/or anxiety had the highest observed risk, at more than four times that of the comparison group.

These are substantial differences, but there is an important word in the study: provisional.

Participants completed screening questionnaires rather than undergoing prospective PMDD diagnosis, and the study was cross-sectional. It can show an association between ADHD and PMDD symptoms, but it cannot tell us that one condition causes the other.

Researchers do not yet know exactly why the overlap exists.

One possibility is that both involve heightened sensitivity to changes in neurotransmitter systems affected by ovarian hormones. Another is that there are overlapping biological, psychological or genetic vulnerabilities.

The answer may involve several of these at once.

So why can the week before your period feel especially difficult?

The late luteal phase creates several changes at the same time.

Oestrogen is falling. Progesterone and allopregnanolone are changing. Premenstrual physical symptoms may appear. Sleep, appetite and mood can change. For someone with ADHD, these changes may be happening on top of existing differences in attention, executive function and emotional regulation.

This may help explain why a task that felt straightforward the previous week can suddenly feel disproportionately difficult.

It is not necessarily that your ADHD has permanently become worse.

The conditions around it have changed.

And this may be why looking only at a monthly or yearly average can miss something important.

The newest research suggests this is very common

The 2026 survey of 600 women is particularly interesting because researchers asked directly about symptoms across hormonal stages.

Among premenopausal participants who were not taking hormone therapy, almost nine in ten reported some change in ADHD symptoms across their menstrual cycle, most commonly worsening during the luteal phase.

That study relied on people remembering and reporting their own symptom patterns, which means it cannot establish the size of the biological effect.

But put it beside daily hormone studies, the 2025 systematic review and the new prospective medication study, and a pattern is beginning to appear.

For at least some women with ADHD, symptoms are not equally intense every day of the month.

What can you actually do with this information?

One of the simplest things may be to look for your own pattern.

If ADHD symptoms, mood, sleep or the perceived effect of medication seem to change around the same point each month, recording them alongside your menstrual cycle for a few cycles can give you something much more useful than trying to remember how you felt three weeks ago.

That does not diagnose PMDD and it does not mean every difficult week is hormonal.

But a repeatable pattern can be useful information to take to a GP, psychiatrist or other relevant healthcare professional, particularly if symptoms become significantly more difficult before menstruation or prescribed medication consistently seems to work differently.

Medication changes should always be discussed with the clinician prescribing them rather than made independently.

What the science actually says

The research is not yet big enough to give every woman with ADHD a menstrual-cycle treatment plan.

The 2025 systematic review found only 11 eligible studies. Several of the most interesting prospective studies contain only 30 or so participants. Medication-adjustment evidence is smaller still.

But the signal is becoming difficult to ignore.

Ovarian hormones interact with neurotransmitter systems involved in attention and executive function. ADHD symptoms have been observed to change across the menstrual cycle. Women with ADHD report particularly frequent worsening in the luteal and menstrual phases. PMDD appears substantially more common among women with ADHD. And researchers are beginning to investigate whether medication response changes alongside those fluctuations.

For decades, women were expected to fit an ADHD model largely built from research in males.

The newer science is asking a different question:

What if ADHD is stable, but the biological environment around it changes across the month?

We do not have the full answer yet.

But we finally have enough evidence to take the question seriously.

References
Osianlis E, Thomas EHX, Li Q, et al. ADHD in females: Survey findings on symptoms across hormonal life stages. Journal of Psychiatric Research. 2026;193:208–215. A survey of 600 female participants reporting ADHD found that 88.6% of premenopausal participants not using hormonal therapy perceived cycle-related changes in ADHD symptoms.
Zaritsky R, Reed SC, Evans SM. Changes in ADHD Symptoms and Mood Across the Menstrual Cycle in Females Treated With Stimulants: A Pilot Study. Journal of Attention Disorders. 2026;30(3):329–341. Thirty participants taking amphetamine salts completed daily symptom tracking across 35 days.
Osianlis E, Thomas EHX, Jenkins LM, Gurvich C. ADHD and Sex Hormones in Females: A Systematic Review. Journal of Attention Disorders. 2025;29(9):706–723. Eleven studies met inclusion criteria, with evidence suggesting links between hormonal changes and ADHD symptom severity.
Eng AG, Nirjar U, Elkins AR, et al. Attention-deficit/hyperactivity disorder and the menstrual cycle: Theory and evidence. Hormones and Behavior. 2024;158:105466.
Roberts B, Eisenlohr-Moul T, Martel MM. Reproductive Steroids and ADHD Symptoms Across the Menstrual Cycle. Psychoneuroendocrinology. 2018;88:105–114. Participants provided daily hormone samples and symptom measures over 35 days.
Bendis PC, Zimmerman S, Onisiforou A, Zanos P, Georgiou P. The impact of estradiol on serotonin, glutamate, and dopamine systems. Frontiers in Neuroscience. 2024;18:1348551.
de Jong M, Wynchank DSMR, van Andel E, Beekman ATF, Kooij JJS. Female-specific pharmacotherapy in ADHD: premenstrual adjustment of psychostimulant dosage. Frontiers in Psychiatry. 2023;14:1306194. Preliminary case series of nine women.
Broughton T, Lambert E, Wertz J, Agnew-Blais J. Increased risk of provisional premenstrual dysphoric disorder (PMDD) among females with attention-deficit hyperactivity disorder (ADHD): cross-sectional survey study. British Journal of Psychiatry. 2025;226(6):410–417.
Hantsoo L, Epperson CN. Towards understanding the biology of premenstrual dysphoric disorder: From genes to GABA. Neuroscience & Biobehavioral Reviews. 2023;149:105168.

This Journal is for general education only and is not medical advice. If cyclical symptoms are significantly affecting daily life, or prescribed ADHD medication appears to work differently across the menstrual cycle, speak with the relevant healthcare professional before making changes to treatment.